
Enhabit Inc.
Healthcare · USD
Price
$14
Cap
$710M
Earnings
3/4 beat
30d Trend
+0%
Near 52-week highs — limited upside before resistance
Target range: $13.8 – $13.8 (consensus: $13.8)
Consensus: Hold
Earnings history
Q4 2025
MET
0.14 vs 0.14
Q3 2025
BEAT
0.17 vs 0.12
Q2 2025
BEAT
0.13 vs 0.1
Q1 2025
BEAT
0.1 vs 0.06
Key macro factors
Aging Demographic and Healthcare Demand: The growing U.S. aging population and increased Medicare Advantage enrollment are driving higher demand for home-based healthcare services to reduce hospital costs.
Labor Shortage in Skilled Nursing: A persistent shortage of skilled nurses in the healthcare sector, particularly in home health, poses challenges for Enhabit in staffing its services, potentially leading to increased labor costs and limiting service expansion.
Medicare Reimbursement Rates and Regulatory Changes: The home health and hospice sector is highly sensitive to policy shifts in Medicare reimbursement rates, including proposed cuts, which could directly impact Enhabit's revenue and overall profitability.
Enhabit, Inc. provides home health and hospice services in the United States, operating under Home Health and Hospice segments.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
